Cargando…

Concomitant Bladder Tumor Is a Risk Factor for Bladder Recurrence but Not Upper Tract

Objective: To evaluate the clinical outcomes of UTUC patients with or without concurrent bladder tumor. Design, Setting, and Participants: The Clinical Research Office of the Endourology Society-Urothelial Carcinomas of the Upper Tract (CROES-UTUC) Registry included 1134 UTUC patients with or withou...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Kang, Zhao, Hongda, Alvarez-Maestro, Mario, Gravas, Stavros, Van Renterghem, Koen, Zeng, Guohua, Ng, Chi-Fai, Laguna, Pilar, Teoh, Jeremy Yuen-Chun, De La Rosette, Jean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776685/
https://www.ncbi.nlm.nih.gov/pubmed/36547141
http://dx.doi.org/10.3390/curroncol29120727
_version_ 1784855922865078272
author Liu, Kang
Zhao, Hongda
Alvarez-Maestro, Mario
Gravas, Stavros
Van Renterghem, Koen
Zeng, Guohua
Ng, Chi-Fai
Laguna, Pilar
Teoh, Jeremy Yuen-Chun
De La Rosette, Jean
author_facet Liu, Kang
Zhao, Hongda
Alvarez-Maestro, Mario
Gravas, Stavros
Van Renterghem, Koen
Zeng, Guohua
Ng, Chi-Fai
Laguna, Pilar
Teoh, Jeremy Yuen-Chun
De La Rosette, Jean
author_sort Liu, Kang
collection PubMed
description Objective: To evaluate the clinical outcomes of UTUC patients with or without concurrent bladder tumor. Design, Setting, and Participants: The Clinical Research Office of the Endourology Society-Urothelial Carcinomas of the Upper Tract (CROES-UTUC) Registry included 1134 UTUC patients with or without concurrent bladder tumor treated between 2014 and 2019. Results: In 218 (19.2%) cases, concurrent bladder tumor was present, while in 916 (80.8%) patients, no bladder cancer was found. In the multivariable Cox regression analysis, concomitant bladder tumor (hazard ratio (HR) 1.562, 95% confidence interval (CI) 0.954–2.560, p = 0.076) indicated a trend associated with recurrence-free survival for UTUC. Further data dissection confirmed that concomitant bladder tumor is a risk factor of bladder recurrence (HR 1.874, 95% CI 1.104–3.183, p = 0.020) but not UTUC recurrence (HR 0.876, 95% CI 0.292–2.625, p = 0.812). Kidney-sparing surgery (KSS) (HR 3.940, 95% CI 1.352–11.486, p = 0.012), pathological T staging ≥ pT2 (HR 2.840, 95% 1.039–7.763, p = 0.042) were significantly associated with UTUC recurrence. KSS does not affect bladder recurrence (HR 0.619, 95% CI 0.242–1.580, p = 0.315). A limitation is the retrospective nature of the present study analysis. Conclusions: The presence of concomitant bladder tumor does not increase risk of UTUC recurrence, but it results in an increased risk of bladder recurrence. KSS does not affect bladder recurrence and can still be considered in patients with concomitant bladder tumor.
format Online
Article
Text
id pubmed-9776685
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97766852022-12-23 Concomitant Bladder Tumor Is a Risk Factor for Bladder Recurrence but Not Upper Tract Liu, Kang Zhao, Hongda Alvarez-Maestro, Mario Gravas, Stavros Van Renterghem, Koen Zeng, Guohua Ng, Chi-Fai Laguna, Pilar Teoh, Jeremy Yuen-Chun De La Rosette, Jean Curr Oncol Article Objective: To evaluate the clinical outcomes of UTUC patients with or without concurrent bladder tumor. Design, Setting, and Participants: The Clinical Research Office of the Endourology Society-Urothelial Carcinomas of the Upper Tract (CROES-UTUC) Registry included 1134 UTUC patients with or without concurrent bladder tumor treated between 2014 and 2019. Results: In 218 (19.2%) cases, concurrent bladder tumor was present, while in 916 (80.8%) patients, no bladder cancer was found. In the multivariable Cox regression analysis, concomitant bladder tumor (hazard ratio (HR) 1.562, 95% confidence interval (CI) 0.954–2.560, p = 0.076) indicated a trend associated with recurrence-free survival for UTUC. Further data dissection confirmed that concomitant bladder tumor is a risk factor of bladder recurrence (HR 1.874, 95% CI 1.104–3.183, p = 0.020) but not UTUC recurrence (HR 0.876, 95% CI 0.292–2.625, p = 0.812). Kidney-sparing surgery (KSS) (HR 3.940, 95% CI 1.352–11.486, p = 0.012), pathological T staging ≥ pT2 (HR 2.840, 95% 1.039–7.763, p = 0.042) were significantly associated with UTUC recurrence. KSS does not affect bladder recurrence (HR 0.619, 95% CI 0.242–1.580, p = 0.315). A limitation is the retrospective nature of the present study analysis. Conclusions: The presence of concomitant bladder tumor does not increase risk of UTUC recurrence, but it results in an increased risk of bladder recurrence. KSS does not affect bladder recurrence and can still be considered in patients with concomitant bladder tumor. MDPI 2022-11-28 /pmc/articles/PMC9776685/ /pubmed/36547141 http://dx.doi.org/10.3390/curroncol29120727 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Liu, Kang
Zhao, Hongda
Alvarez-Maestro, Mario
Gravas, Stavros
Van Renterghem, Koen
Zeng, Guohua
Ng, Chi-Fai
Laguna, Pilar
Teoh, Jeremy Yuen-Chun
De La Rosette, Jean
Concomitant Bladder Tumor Is a Risk Factor for Bladder Recurrence but Not Upper Tract
title Concomitant Bladder Tumor Is a Risk Factor for Bladder Recurrence but Not Upper Tract
title_full Concomitant Bladder Tumor Is a Risk Factor for Bladder Recurrence but Not Upper Tract
title_fullStr Concomitant Bladder Tumor Is a Risk Factor for Bladder Recurrence but Not Upper Tract
title_full_unstemmed Concomitant Bladder Tumor Is a Risk Factor for Bladder Recurrence but Not Upper Tract
title_short Concomitant Bladder Tumor Is a Risk Factor for Bladder Recurrence but Not Upper Tract
title_sort concomitant bladder tumor is a risk factor for bladder recurrence but not upper tract
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776685/
https://www.ncbi.nlm.nih.gov/pubmed/36547141
http://dx.doi.org/10.3390/curroncol29120727
work_keys_str_mv AT liukang concomitantbladdertumorisariskfactorforbladderrecurrencebutnotuppertract
AT zhaohongda concomitantbladdertumorisariskfactorforbladderrecurrencebutnotuppertract
AT alvarezmaestromario concomitantbladdertumorisariskfactorforbladderrecurrencebutnotuppertract
AT gravasstavros concomitantbladdertumorisariskfactorforbladderrecurrencebutnotuppertract
AT vanrenterghemkoen concomitantbladdertumorisariskfactorforbladderrecurrencebutnotuppertract
AT zengguohua concomitantbladdertumorisariskfactorforbladderrecurrencebutnotuppertract
AT ngchifai concomitantbladdertumorisariskfactorforbladderrecurrencebutnotuppertract
AT lagunapilar concomitantbladdertumorisariskfactorforbladderrecurrencebutnotuppertract
AT teohjeremyyuenchun concomitantbladdertumorisariskfactorforbladderrecurrencebutnotuppertract
AT delarosettejean concomitantbladdertumorisariskfactorforbladderrecurrencebutnotuppertract